POPULARITY
Categories
(June 24, 2026) The dispute over events for America’s 250th birthday. Americans are in denial about elder care. Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany speaks onSee omnystudio.com/listener for privacy information.
In this episode of Future of Fitness, host Eric Malzone sits down with Dr. Tania Elliott—board-certified physician, three-time Chief Medical Officer, and a leading voice in healthcare innovation—to break down the collision course between the fitness industry and the future of preventative health. Dr. Elliott doesn't hold back: she calls out the fitness world for being too intense or too dainty, challenges the gatekeeping role of primary care, and paints a vivid picture of what the health club of the future should really look like. From the over-reliance on protocols and biohacking to the untapped power of community, nutrition, and strength training for women, this conversation is a bold, no-BS look at how fitness can evolve from a destination into a way of life. If you're ready to rethink everything you know about health, wellness, and the role of gyms in healthcare, this one's for you.
What if your ring knew you were getting sick before you did and could one day monitor chronic conditions around the clock? In this episode, Dr. Ricky Bloomfield, Chief Medical Officer of Oura, explores how continuous health monitoring with wearable devices is shifting health care from reactive treatment to early prevention. The Oura Ring can detect illness days before symptoms appear, from COVID to lymphoma to appendicitis, because earlier diagnosis can make all the difference. Rings are becoming the wearable of choice. By tracking meaningful metrics such as cardiovascular age and cumulative stress scores, people can act on what they see, adjusting diet, exercise and sleep habits and watching their health improve. Finally, Dr. Bloomfield unpacks what it will take for wearable data to be meaningfully integrated into clinical care. He also explores how AI is transforming the health care landscape, from Oura Advisor, an AI-powered tool that lets users query and understand their own health data, to AI-generated summaries designed to highlight the most important and actionable insights for doctors.
As a country, we're living longer than ever before. The average life expectancy in the United States is now 79 years old, according to the Centers for Disease Control. But how are we doing when we get to our golden years? In Ohio, the answer is not necessarily the best, according to the latest America's Health Rankings Senior Report. This study from The United Health Foundation ranked Ohio 36th in the country in overall health for seniors. Some major concerns include suicide rates, drug related deaths, poverty and food insecurity concerns and levels of physical activity. When you add in concerns about mental function and emotional wellbeing, there's a lot to think about as we age. On Tuesday's edition of the "Sound of Ideas," we're looking at what we can do in our younger years to try to maintain our mental, emotional and physical health for as long as our bodies will let us. Guests: - Gary Grosel, M.D., Chief Medical Officer, UnitedHealthcare of Ohio - Lester Carney, age 92, Olympic athlete who won a silver medal in the 200-meter dash at the 1960 Summer Olympics in Rome, Italy - Robert Bermel, M.D., Staff Neurologist, Neurological Institute's Mellen Center for Multiple Sclerosis at Cleveland Clinic - Roopa Anmolsingh, M.D., Lead Geriatrician for Community Programs, Cleveland Clinic
Chief Medical Officer at Central DuPage Hospital Dr. Tom Moran joins Wendy Snyder (in for Bob Sirott) to discuss a study that focuses on how Ozempic could cut the risk of broken bones and its original purpose for diabetics. He also looks at a couple other studies that talk about what eliminating sugar can do […]
On this episode host Raj Sundar sits down with Dr. Evans, CEO, Chief Medical Officer, and co-founder of the Wellness Equity Alliance, to explore how trust is built with historically marginalized communities in healthcare. They trace his journey from international humanitarian crises to leading vaccine distribution and street medicine initiatives in the U.S., digging into the intersections of operational efficiency, health equity, and the imperative for wellness—not just disease prevention. Together, they discuss the importance of understanding patients' full social histories, culturally responsive practices, and the role of branding in building institutional trust. They challenge the politicization of public health, examine the roots of distrust and trauma in marginalized communities, and call for clinicians to think creatively, form cross-sector partnerships, and unite in the face of systemic challenges to rebuild equitable systems of care. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/
Join Maria Gaitanidou, Co-Founder and CEO of Hati Health, for a deep dive into the financial and operational mechanics redefining healthcare access across Southeast Asia. In a region where nearly 40% of medical spending is paid entirely out-of-pocket, the historic hurdle isn't a lack of consumer willingness to pay—it is a hyper-fragmented, opaque, and physically inaccessible ecosystem. Drawing from her extensive career at the absolute frontier of Southeast Asia's digital finance and banking revolution, Maria is applying fintech orchestration principles to the healthcare sector. In this episode, we explore how Hati Health is constructing a unified marketplace layer that connects millions of patients to 160+ partner networks without owning a single brick-and-mortar clinic.
Ketamine Therapy, MDMA, Psilocybin, and the Science of Psychedelic Assisted Healing Most people struggling with depression, anxiety, and trauma have never felt safe in their nervous system, and the treatments they have been prescribed are making that worse. This episode breaks down the neuroscience of psychedelic therapy, why ketamine is the safest and most accessible starting point, how MDMA triggers a BDNF dependent pathway that repairs trauma all the way down to the epigenetic code, and why your antidepressant may be blocking the very brain states required for real healing. -Watch this episode on YouTube for the full video experience: https://www.youtube.com/@DaveAspreyBPR -Order Dr. Rabin's Book ‘A Simple Guide to Being Alive': https://apolloneuro.com/pages/a-simple-guide-to-being-alive Host Dave Asprey sits down with Dr. Dave Rabin, MD, PhD, a senior research scientist at the Florida Institute for Human and Machine Cognition, Executive Director of The Board of Medicine, and co-founder and Chief Medical Officer of Apollo Neuroscience. Dr. Rabin received his MD and PhD in neuroscience from Albany Medical College and specialized in psychiatry at the University of Pittsburgh Medical Center. He has spent 20 years studying chronic stress and non-invasive therapies for treatment-resistant illness, and his primary research on MDMA assisted therapy for severe PTSD has demonstrated that trauma can be reversed at the epigenetic level, offering a genuine path to a cure. His upcoming book A Simple Guide to Being Alive publishes June 1, 2026 and is a science-backed manual for anyone who has ever felt overwhelmed by the modern world. Dave and Dr. Rabin break down why nearly 50% of people prescribed psychiatric medication never achieve remission, why SSRIs and SNRIs physically block the brain states required for emotional healing, and why the FDA rejected MDMA therapy after three trials showed an 88% response rate. They dig into the exact BDNF pathway that makes MDMA and ketamine so transformative, how psychedelics amplify safety learning in the amygdala at the molecular level, and why trauma passes down up to 14 generations through epigenetic code that can now be measured and repaired. They also cover why your breathing rate at the doctor's office is already a stress signal nobody is reading, how your smartphone puts your nervous system into a chronic fear state before you even get out of bed, and why ketamine is the right starting point for anyone curious about psychedelic therapy right now. You'll Learn: Why nearly 50% of psychiatric patients never get better and what treatment-resistant actually means How ketamine therapy works, why it is legal in every state, and why it is the safest place to start The exact BDNF pathway through which MDMA repairs fear extinction in the amygdala How MDMA assisted therapy produces measurable epigenetic repair of the cortisol receptor gene damaged by trauma Why SSRIs and SNRIs block the insula mediated brain states required for real emotional healing Why combining serotonergic psychedelics with SSRIs puts you at risk of life-threatening serotonin syndrome Why trauma passes down up to 14 generations and what you can do to stop the cycle now Why smartphones put your nervous system into a toxic overstimulation state before the day even starts How the FDA rejected MDMA therapy after 88% of patients responded and who paid to make that happen Thank you to our sponsors! - Qualia | If you want to take the guesswork out of maintaining high NAD+ levels as you age, go to www.qualialife.com/daveNAD to get clinically proven Qualia NAD+ backed by a 100 day money back guarantee and code DAVENAD at checkout gets you an extra 15% off. - iRestore | Reverse hair loss at www.irestore.com/DAVE and get exclusive savings on the iRestore Elite, use code DAVE - OneSkin | For a limited time, try OneSkin with 15% off at oneskin.co/DAVE. - LMNT | Right now you can get a free 8-count Sample Pack of LMNT's most popular drink mix flavors with any purchase at drinkLMNT.com/dave Dave Asprey is a four-time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade brings you the knowledge to take control of your biology, extend your longevity, and optimize every system in your body and mind. Each episode delivers cutting-edge insights inhealth, performance, neuroscience, supplements, nutrition, biohacking, emotional intelligence, and conscious living. New episodes are released every Tuesday, Thursday, Friday, and Sunday (BONUS). Dave asks the questions no one else will and gives you real tools to become stronger, smarter, and more resilient. Keywords: Dave Rabin, Dr. Dave Rabin, Apollo Neuroscience, A Simple Guide to Being Alive, ketamine therapy, MDMA assisted therapy, psilocybin therapy, psychedelic assisted therapy, treatment-resistant depression, treatment-resistant mental illness, BDNF pathway, fear extinction amygdala, vagus nerve activation, trauma epigenetics, cortisol receptor gene, epigenetic repair, serotonin syndrome, SSRI alternatives, MDMA BDNF, ketamine BDNF, nervous system safety, autonomic nervous system, parasympathetic nervous system, generational trauma, trauma self-trust, MAPS MDMA trial, FDA MDMA rejection, pharmaceutical interference MDMA, breathing rate stress, smartphone nervous system, Apollo Neuro wearable, Board of Medicine, theboardofmedicine.org, insula cortex, psychedelic safety protocol, ketamine legal therapy, MDMA 88 percent, bottom-up learning psychedelics, trauma fractured self-trust, 14 generations trauma, stress breathing range Resources: • Order Dr. Rabin's Book ‘A Simple Guide to Being Alive': https://apolloneuro.com/pages/a-simple-guide-to-being-alive • Purchase Dr. Fotuhi's New Book The Invincible Brain: https://a.co/d/0iHCgPpL • Get My 2026 Clean Nicotine Roadmap | Enroll for free at https://daveasprey.com/2026-clean-nicotine-roadmap/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Join My Substack (Live Access To Podcast Recordings): https://substack.daveasprey.com/ • Upgrade Labs: https://upgradelabs.com Timestamps: 00:00 – Trailer 01:34 – Dave Rabin Introduction 05:01 – Psychedelics and Psychiatry 08:35 – Psychedelic Safety and Dosing 14:53 – Serotonin Syndrome Warning 21:17 – Vagus Nerve and Safety 27:36 – Smartphones and Chronic Stress 34:18 – Defining Trauma 38:00 – Trauma and Epigenetics 40:23 – MDMA Cortisol Gene Repair 44:44 – Therapy vs. Medicine Alone 49:15 – FDA MDMA Rejection 55:35 – Ketamine Personal Experience 59:15 – Closing and Book Recommendation See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Vertical jump improved by over three centimetres in elite soccer players after just six weeks, simply by targeting one overlooked part of cellular biology: the mitochondria. Angela Foster talks with Dr Anurag Singh, Chief Medical Officer at Timeline, about the science of mitophagy, the process that clears out dysfunctional mitochondria, and how the clinically studied compound urolithin A supports it. They walk through real clinical trial data spanning soccer players, elite weightlifters and Olympic-level runners, with a particular focus on findings in women, exploring measurable gains in strength, power and recovery markers like reduced muscle damage and perceived effort. Listeners will learn why mitochondrial renewal takes weeks rather than days to show up, what it actually means when energy dips after stopping supplementation and rebounds on restarting, and why this matters especially for women navigating perimenopause, when recovery and inflammation can shift noticeably. Tune in to understand what's really happening at the cellular level behind your energy and recovery. KEY TAKEAWAYS Understand mitochondrial health as a three-stage cycle: biogenesis (creating new mitochondria), fission and fusion (making existing ones more efficient), and mitophagy (clearing out dysfunctional ones). Neglecting that final clearance step is, as Dr Singh puts it, like never taking the garbage out of a cluttered house. Expect mitochondrial and performance benefits to build gradually rather than instantly. Clinical studies show improved mitochondrial health in muscle tissue after one month, with measurable strength and power gains showing up after two to four months, so don't judge a mitochondria-targeted intervention by how you feel after a week. Pay attention to recovery markers, not just strength numbers, when evaluating training interventions. In a four-week study with elite runners, those taking mitopure showed lower rate of perceived exertion and lower creatine kinase, a muscle damage marker, suggesting easier recovery rather than just raw performance gains. Try a deliberate break from a supplement or intervention to gauge whether it's actually working for you. Both Angela and Dr Singh independently noticed an energy dip after stopping urolithin A supplementation, which is a practical way to separate real effect from placebo. Look for research that specifically includes women, since women are historically underrepresented in supplement and performance studies. Timeline's trials run roughly two-thirds female participants, which matters for understanding how recovery and inflammation patterns shift during phases like perimenopause. STANDOUT QUOTES "If we have a super cluttered house, there's only so much we can do to improve it. At one point, we've got to take out the garbage." — Dr Anurag Singh "Rome wasn't built in a day." — Dr Anurag Singh "It's the only thing we know outside of exercise and fasting that hits that mitochondria specific autophagy." — Dr Anurag Singh "I feel like I can do everything and have fun with my kids." — Angela Foster "That's the reason we're doing all this, right? It's our life. We want to live it healthily, fully." — Dr Anurag Singh VALUABLE RESOURCES • Take the BioSyncing Quiz to help you understand what's actually happening in your body and how to fix it.
Traditional clinical interviews can have up to a 50% variance in ADHD diagnosis, leaving the door wide open for implicit bias. By utilizing machine learning-enabled, asynchronous assessments, Mentavi Health is wringing out biases related to race, gender, and appearance, and dropping the false-positive rate to just 12%. In this episode, host Peter Fenger speaks with Dr. Barry K. Herman, Chief Medical Officer at Mentavi Health. A Stanford-trained, board-certified adult and child psychiatrist with over 25 years of experience across managed care, pharmaceuticals, and digital health, Dr. Herman is a past president of AAPAL and a prolific researcher with over 100 scientific publications to his name. Join us as we explore Dr. Herman's non-linear journey from traditional practice to population health, the clinical validation behind the Mentavi Diagnostic Evaluation, and how decoupling diagnosis from treatment is fundamentally shifting the timeline, accuracy, and accessibility of online mental health care. For more information about Mentavi Health, please visit: https://mentavi.com For more information about Mentavi Health's Diagnostic Evaluation, please visit: https://mentavi.com/diagnostic-evaluation/ For more information about their assessment validation study, please visit: https://mentavi.com/press-release/mentavi-health-announces-results-from-first-of-its-kind-adhd-assessment-validation-study/ Connect with Mentavi Health on social media: On Instagram: https://www.instagram.com/mentavi_health/ On Linkedin: https://www.linkedin.com/company/mentavihealth/ On YouTube: https://www.youtube.com/@mentavihealth On Facebook: https://www.facebook.com/people/Mentavi/100085316731601/ On X: https://x.com/MentaviHealth
In this episode, Dr. Brendan McCarthy breaks down one of the most misunderstood topics in hormone replacement therapy: estradiol. Not all estrogen is the same—and how estradiol is delivered can dramatically affect hormone balance, inflammation, clotting risk, testosterone levels, and overall health outcomes. Dr. McCarthy discusses: • Why route of administration matters (oral, patch, injectable, topical, vaginal, pellet) • How oral estradiol converts to estrone • The differences between estradiol (E2), estrone (E1), and estriol (E3) • Estrone's relationship to inflammation and metabolic health • Oral estrogen and clotting risk • Oral estrogen's effect on SHBG and free testosterone • The impact of oral estrogen on IGF-1 and growth hormone signaling • Why informed consent should be central to hormone therapy • Benefits and limitations of pellets, patches, creams, and injections • Estriol and emerging research in autoimmune conditions such as multiple sclerosis At Protea Medical Center, our philosophy is simple: patients deserve complete information so they can make empowered decisions about their health.
The Call Before the Crisis: Ken Duckworth on Men, Mental Health, and the Families Who Notice First The Not Old Better Show, Healthy Living Interview Series A man can say "I'm fine" and still may be asking, in the only way he knows how, for someone to notice. That is where this episode begins.
(June 17, 2026) Records reveal $600MIL estimate for President Trump’s ballroom project, with half from taxpayers. California commission seeks to fix broken public defense system. Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany speaks on GLP-1s possibly improving male fertility, the relationship between COVID and cancer, and antibacterial is NOT better than soap.See omnystudio.com/listener for privacy information.
In this episode, Dr. Andy Cutler talks with Dr. Bhagwan Bahroo about nutritional interventions in psychiatry, including diet, supplements, metabolic health, inflammation, and the gut-brain axis. They explore where the evidence is strongest, where hype outpaces the data, and how clinicians can discuss nutritional strategies as adjunctive tools without losing focus on core treatments. Bhagwan A. Bahroo, MD, DLFAPA, is a board-certified psychiatrist in adult, addiction, and forensic psychiatry and an Assistant Professor at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. He has extensive clinical experience at Walter Reed National Military Medical Center and has worked in interventional psychiatry, including TMS and esketamine, with an interest in nutrition and its role in mental health. Andrew J. Cutler, MD, is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and EMA Wellness. He is a Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York. Fall Congress Get $100 off NEI Fall Congress registration with code POD26. Go to https://nei.global/fall to sign up today! Never miss an episode!
This episode is sponsored by Bluesky CBD and Alloy. Bluesky CBD: Get to sleep faster, experience more restorative sleep and save 30% with code FLIPPING50 at https://www.bluesky-cbd.com/discount/Flipping50. Alloy - Get your menopause treatment plan today. Visit https://myalloy.com and use code FLIPPING50 for $20 off your first order! #AgeGracefully Other Episodes You Might Like: Previous Episode - 25 Simple Rules for Optimal Health, Wellness & Fitness over 50 Next Episode - Muscle and Strength Loss Prevention After 50: A Checklist More Like This - What Is Sarcopenia and How to Avoid Sarcopenia In Menopause Resources: Get YOLKED with Fortetropin, a revolutionary supplement that helps fuel muscle growth and enhance recovery. Get powered by Mitopure®! The nutrient that can re‑energize cells with a breakthrough for healthy aging. Use code FLIPPING50 to claim your 20% discount. Collagen Boost is an unflavored source of bioactive collagen peptides designed to support skin and nails as well as healthy joints, bones, ligaments, and tendons. Use code PODCOLLAGEN10 to claim your 10% discount. Try the Lofta Home Sleep Test for sleep apnea in the comfort of your own home. Use Flipping 50 Scorecard & Guide to measure what matters with an easy at-home self-assessment test you can do in minutes. Muscle loss and sarcopenia have been synonymous with aging in previous generations. Muscle loss impacts osteoporosis, balance, stability, independence, and hormone balance. In this episode we'll talk about the 3 M's and how to bank muscle looking forward to a time off your fee as well as how to get it back if you have muscle loss and sarcopenia. My Guest: Dr. Chris Meletis is an internationally recognized educator, author, lecturer, and functional medicine practitioner with more than 33 years of clinical experience. He has authored 18 books and over 200 scientific articles, contributing extensively to the fields of naturopathic and integrative medicine. Formerly the Dean of Naturopathic Medicine and Chief Medical Officer at the National College of Naturopathic Medicine, he was honored as Physician of the Year by the American Association of Naturopathic Physicians. Passionate about accessible healthcare, he helped establish 16 free natural medicine clinics and continues to focus on the GI microbiome, mitochondrial health, nutritional biochemistry, and botanical medicine. Questions We Answer in This Episode: What trends have you seen in aging, and why does muscle become such a critical issue for women in midlife and beyond? Are physicians beginning to use muscle-related assessments as vital signs, and should strength be monitored more routinely as we age? What does grip strength actually measure, and why is it such a powerful indicator of overall strength and future health? What happens when you need a bunion surgery, joint replacement, or another procedure that temporarily limits activity? Will you lose muscle, and how can you prepare for it? If you're told to lose weight before a knee or hip replacement, how do you protect muscle mass while improving your health outcomes? Are we eating enough protein, and is our digestion allowing us to actually absorb and utilize it as we age? How can muscle-support strategies help during periods of bed rest, illness, pain, long COVID, or other situations that increase the risk of sarcopenia? What should active women do when they're already exercising but still struggle with maintaining muscle, energy, or lean body mass? If this episode made you flip your workout routine — share it!
In this episode, Andy Anderson, MD, MBA, Chief Medical and Quality Officer at RWJBarnabas Health, joins the podcast to discuss how healthcare organizations are navigating rapid changes in automation and digital transformation. He shares insights on the evolving responsibilities of clinical and technology leaders, highlighting how the roles of Chief Medical Officers and Chief Information Officers are becoming increasingly interconnected as organizations work to improve care delivery, quality, and operational performance.
In this episode, Dr. Michael Han, Chief Medical Officer, Ambience Healthcare, discusses how ambient AI is reducing clinician burnout, improving documentation quality, and driving adoption at scale by focusing on clinician trust, workflow integration, and measurable outcomes.This episode is sponsored by Ambience Healthcare.
In oncology, performance is not just about getting patients in the door. It is about getting them to the right specialist, at the right time, with less friction across every handoff. This episode features a presentation from the ROI-Centered Care Summit, a half-day virtual summit produced by Bright Spots Ventures in partnership with TytoCare and the American Telemedicine Association (ATA). In this episode, Yarrow McConnell, MD, FACS, Chief Medical Officer at MultiCare Cancer Institute, shares how MultiCare redesigned oncology pathways to improve access, strengthen coordination, and deliver measurable ROI. You'll hear how MultiCare is: Using AI chart scrubbing to identify cancer diagnoses and concerning imaging findings earlier Deploying nurse navigators to accelerate intake and reduce barriers to care Building APP-staffed workup clinics to move patients more quickly from referral to consult Creating disease teams to improve handoffs and reduce siloed care Standardizing scheduling and authorization workflows, with virtual options built in Improving staging and comorbidity documentation to better reflect complexity and reimbursement Key topics include referral lag, nurse navigation, specialty coordination, scheduling friction, and the connection between operational redesign and financial performance. MultiCare reported a 9% year-over-year increase in operating margin, an increase in likelihood to recommend from 97.86 to 98.41, and a 17% year-over-year increase in teamwork scores. If you are a health system leader, oncology executive, specialty operations leader, or care transformation leader working to improve specialty access and reduce friction across the patient journey, this episode offers a practical look at what it takes to build specialty pathways that perform. Link to Dr. Yarrow McConnel's Presentation: https://www.brightspotsinhealthcare.com/wp-content/uploads/2026/06/ROI-navigation-AIintake-McConnell-2026.pdf Bio: Yarrow McConnell, MD, MSc, FACS, FSSO, is a board-certified surgical oncologist, specializing in the treatment of breast cancer and benign breast disorders. Her expertise includes lumpectomy, mastectomy, sentinel node biopsy, and axillary dissection. She is also highly skilled in oncoplastic techniques to restore breast contour and symmetry following cancer surgery. For patients pursuing reconstruction, Dr. McConnell performs skin and nipple sparing mastectomies in close collaboration with plastic surgeons to provide both immediate and delayed reconstruction options. She also offers flat aesthetic closure for those who choose not to undergo reconstruction. In complex cases involving inflammatory, recurrent, or locally advanced breast cancer, she is experienced in performing modified radical and radical mastectomies. In addition to cancer care, Dr. McConnell treats a variety of benign breast conditions through both in-office and surgical procedures, including cyst aspiration, duct excision, abscess drainage, and steroid injections. She also provides comprehensive breast cancer risk assessments and guidance on genetic testing, enhanced screening, and prevention strategies. Dr. McConnell leads the Breast Program at MultiCare Cancer Institute, overseeing the coordination and advancement of breast care services across the system. Outside of work, Dr. McConnell enjoys gardening, baking, woodworking, and knitting. She can often be found hiking with her husband and dogs or spending time with family and friends. Thank You to Our Episode Partner, TytoCare. TytoCare enables health systems and plans to deliver high-quality remote exams anytime, anywhere. Their FDA-cleared devices and AI-powered diagnostic platform support virtual specialty care, school-based programs, and home health models, reducing unnecessary ED visits and improving patient experience. To learn more, visit tytocare.com. Schedule a Meeting with a Senior Leader at TytoCare: To explore how TytoCare can help your organization expand virtual specialty access and improve care coordination, reach out to jtenzer@brightspotsventures.com to schedule a meeting. About Bright Spots Ventures: Bright Spots Ventures exists to help healthcare organizations accelerate the adoption of what's actually working. Healthcare does not suffer from a lack of innovation. It suffers from slow adoption, fragmented learning, and limited trust between stakeholders. For example, one health plan or provider may solve a major operational or clinical challenge while others spend the next 5–10 years rediscovering the same answer. We close that gap by creating trusted environments where health plans, providers, and innovators can share practical strategies, operational lessons, and scalable models that drive measurable improvement. Through the Bright Spots in Healthcare podcast, leadership councils, executive roundtables, curated events, and strategic advisory work, we help organizations build credibility, strengthen strategic relationships, and accelerate the spread of proven ideas across healthcare.
Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about a new study that shows GLP-1 medications may improve male fertility, and why you should be aware of your blood pressure and pulse pressure.
Are you suffering from chronic "adult tiredness," or wondering why you immediately get sick the second you finally go on vacation? In this episode of Beauty Bytes, I am joined by Dr. Scott Sherr, a board-certified internal medicine physician, specialist in hyperbaric oxygen therapy, and leader in health optimization medicine. We are doing a massive deep dive into the true powerhouse of your cells: the mitochondria. With only 6% of the US population having optimized mitochondrial function, it is no wonder so many of us are completely exhausted. Dr. Sherr explains why the traditional approach to feeling better is backward, revealing why you must fix your cellular energy before trying to lower your stress and anxiety. We also talk about a fascinating synthetic compound called methylene blue. Dr. Sherr explores how taking it via buccal troches can hack jet lag, eliminate brain fog, and safely jumpstart your biological system. Plus, we cover the real science of hyperbaric oxygen therapy and why your skin is actually your "reverse gut".Guest Information: Dr. Scott Sherr is the Chief Medical Officer of Troscriptions and One Base Health. You can find his products at troscriptions.com and learn more about his health optimization practice at drscottsherr.com.
David Stamler, M.D., Chief Executive Officer AlterityTherapeuticsAlterity Therapeutics (NASDAQ: ATHE & ASX: ATH)www.alteritytx.com David Stamler, M.D., Chief Executive OfficerDavid Stamler, M.D. is Chief Executive Officer and a Managing Director, and previously served as Alterity's Chief Medical Officer and Senior Vice President, Clinical Development. Dr Stamler has extensive drug development expertise spanning early-stage research through late-stage clinical trials, with three FDA drug approvals in neurology.Prior to joining Alterity, Dr. Stamler served as the Vice President, Clinical Development and Therapeutic Head for Movement Disorders at Teva Pharmaceutical Industries after Teva acquired Auspex Pharmaceuticals where he was Chief Medical Officer.Prior to Auspex, he served as Senior Vice President and Chief Medical Officer at XenoPort, Inc., and Head of Drug Development at Prestwick Pharmaceuticals, Inc. Before Prestwick, Dr. Stamler worked at Fujisawa Pharmaceutical Co. and its subsidiaries in various leadership roles, including Vice President, Research and Development, Medical Sciences at Fujisawa Healthcare, Inc., and as Vice President, Clinical Research Center at Fujisawa Research Institute of America. Dr. Stamler began his career at Abbott Laboratories where he served in various positions including Director of Clinical Research, Pharmaceutical Products for the International Division.Dr. Stamler received an M.D. from the University of Chicago—The Pritzker School of Medicine and a B.A. in Biology from the University of Chicago.
Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about a new study that shows GLP-1 medications may improve male fertility, and why you should be aware of your blood pressure and pulse pressure.
Dr. Jim Adams, Chief Medical Officer at Northwestern Medicine, joins Lisa Dent to discuss recent health headlines. Dr. Adams first addresses whether or not the Ebola outbreak currently in Congo will spread to the Americas as well as how one out every three adults misunderstands medical directions. He later highlights prostate health as we continue […]
Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about a new study that shows GLP-1 medications may improve male fertility, and why you should be aware of your blood pressure and pulse pressure.
“Neuroscience is what oncology was 20 years ago,” says Cristian Massacesi, Chief Medical Officer and Head of Development at Bristol Myers Squibb. Massacesi joins Bloomberg Intelligence pharmaceuticals analyst Sam Fazeli to discuss Bristol Myers’ push into neuroscience, including Alzheimer’s therapies aimed at tau, a protein tied to brain tangles in the disease. They also explore the company’s oncology pipeline, including PD-L1/VEGF bispecifics, next-generation antibody-drug conjugates and advances in multiple myeloma. Massacesi explains how Bristol is balancing internal innovation with external partnerships and why AI could fundamentally change the economics and success rates of drug development.See omnystudio.com/listener for privacy information.
In this episode, host Sandy Vance chats with Brad Schoffstall, Vice President of Health and Compliance Programs at CGI, and Dr. James Peake, Senior Vice President and former Secretary of Veterans Affairs and Army Surgeon General. They have a wide-ranging and practical conversation about what it actually takes to modernize data infrastructure at federal health agencies. With Brad's 35 years at CGI and Dr. Peake's 16 years, this is a conversation grounded in hard-won experience rather than theory. Today's conversation is a refreshingly honest and deeply practical perspective for anyone working at the intersection of government, healthcare, and AI. In this episode, they talk about: Federal health agencies are running some of the largest healthcare operations in the world, with the VA equivalent in size to a Fortune 5 company Data silos created by contract-by-contract procurement are the primary barrier to AI-ready infrastructure at federal agencies Federated data platforms allow data to stay in its own repositories while being discoverable, mappable, and usable across the organization Policy is often the biggest obstacle to data sharing, and changing it requires executive-level support and shared governance Technology is the third most important factor in transformation; policy and business understanding come first and second CGI improved NHS Spine performance tenfold while reducing infrastructure to a tenth of its original size, saving a million euros in annual expenses Improper payments across federal health programs run into billions of dollars annually and represent one of the highest-impact areas for AI-driven improvement AI for AI's sake is not the answer; start with the business problem and work backward to the data strategy Start small with two or three systems, demonstrate value, and build from there rather than attempting a massive all-at-once implementation A Little About Brad and James: Brad Schoffstall has wide-ranging experience, deep knowledge, and skills in information technology. He has led multiple digital transformation efforts. He has 37 years of experience with a diverse set of architectures, operating systems, languages, and technologies. His experience includes enterprise architecture, cloud migration, and hands-on development. He also has significant experience in business development and project management. He has implemented large, complex systems on platforms ranging from mainframes to Microservices. He has successfully performed many solution architecture and SDLC engagements that include characteristics like high-volume processing, DevOps, and automation. He demonstrates expertise in multiple service-based secure architectures utilizing multiple application and enterprise solution sets, e.g., Data Driven, Microservices, Cloud, etc. Dr. James Peake is an American politician and former lieutenant general who served as the sixth Secretary of Veterans Affairs from 2007 to 2009. In 2004, he retired from a 38-year United States Army career, having served as the 40th Surgeon General of the United States Army. After retiring from the Army, Peake served as Executive Vice President and Chief Operating Officer of Project Hope,[4][5] a non-profit international health foundation operating in more than 30 countries. While at Project HOPE, he helped to orchestrate the use of civilian volunteers aboard the Navy Hospital Ship Mercy as it responded to the tsunami disaster in Indonesia and also as part of the Hurricane Katrina response aboard the Hospital Ship Comfort. Just before he was nominated Secretary of Veterans Affairs, Peake served as Chief Medical Officer and Chief Executive Officer for QTC, one of the largest private providers of government-outsourced occupational health and disability examination services in the nation.
Overview: We sit down with Dr. Evans, CEO, Chief Medical Officer, and co-founder of the Wellness Equity Alliance, to explore how trust is built with historically marginalized communities in healthcare. We trace his journey from international humanitarian crises to leading vaccine distribution and street medicine initiatives in the U.S., digging into the intersections of operational efficiency, health equity, and the imperative for wellness—not just disease prevention. Together, we discuss the importance of understanding patients' full social histories, culturally responsive practices, and the role of branding in building institutional trust. We challenge the politicization of public health, examine the roots of distrust and trauma in marginalized communities, and call for clinicians to think creatively, form cross-sector partnerships, and unite in the face of systemic challenges to rebuild equitable systems of care. Three Takeaways: 1. Building Trust Requires Concrete, Ongoing Actions Trust in healthcare, especially with historically marginalized communities, isn't achieved by grand gestures but through small, consistent acts—like greeting patients in their native language, deep dives into their social histories, and intentionally leaving the white coat behind to signal approachability. These deliberate choices help disarm skepticism and make patients feel seen and respected 2. Talking about health equity isn't enough. Real progress demands operational systems that prioritize efficiency while centering equity. Relying solely on passion or “feel-good” projects fails marginalized populations; instead, balancing efficiency with access and sustainability is critical for lasting impact 3) Rebuilding Healthcare Will Require Broad, Cross-Sectoral Collaboration A radical rebuild of public health and healthcare systems can't rely on clinicians alone. Collaboration across tech, finance, pharma, and beyond is necessary to imagine and operationalize scalable, sustainable models that serve everyone—especially those currently left behind. Learning from global best practices can help reimagine what's possibl Book: Pandemics, Poverty and Politics Next Step: Visit our website, Healthcare for Humans, and join our community to enjoy exclusive benefits at https://www.healthcareforhumans.org/support/ Support Our Mission: Non-clinicians, explore exclusive content and contribute to our collective journey. Be an Active Participant: Go beyond listening. Shape our narrative by co-creating episodes with us. Be part of our community by visiting https://www.healthcareforhumans.org/support/. Follow us on Instagram @healthcareforhumanspodcast
Clinical trials save lives but why does it often take years before a study can enroll its first patient? In this episode of The Lebanese Physicians Podcast, Dr. Khalil Diab sits down with oncologist, physician executive, author, and Chief Medical Officer of Ryght AI, Chadi Nabhan, to explore how artificial intelligence is transforming clinical trial site selection, feasibility assessments, and study activation. Dr. Nabhan explains why so many clinical trials struggle with enrollment, how traditional site selection methods often rely on relationships rather than data, and how AI-powered "digital site twins" may help identify the best-performing research centers worldwide. The discussion also explores the future of clinical research, reducing trial delays, increasing diversity in enrollment, and accelerating access to life-saving therapies. Topics discussed include: ✅ Why clinical trials often take 10–12 years to complete ✅ The hidden costs of poor site selection ✅ How AI-powered site twins work ✅ Clinical trial feasibility and site activation ✅ Enrollment prediction and trial performance ✅ Community practices vs academic medical centers ✅ Diversity, equity, and bias in AI-driven research ✅ The future of AI in clinical trials and drug development ✅ How faster trials could bring treatments to patients sooner Whether you're a physician, researcher, clinical trial professional, healthcare executive, or simply interested in the future of medicine, this conversation offers a fascinating look at how AI may reshape clinical research for years to come.
After 16 episodes exploring food, metabolism, cravings, and health, Dr. Brendan McCarthy shares the most important lesson of all: Your body is not broken. Too often, health conversations focus on calories, diets, lab results, and willpower. But lasting change isn't just about what you eat—it's about understanding why you eat, what your body is responding to, and replacing shame with compassion. In this powerful conclusion to the series, Dr. McCarthy reflects on years of working with women who have been told they are the problem, only to discover that healing begins when someone finally listens. In this episode: ✔ Why comfort foods affect more than hunger ✔ How food impacts brain chemistry and emotional regulation ✔ The hidden reason diets often fail long-term ✔ Why shame keeps people stuck in unhealthy cycles ✔ The importance of self-compassion and sustainable change ✔ "We don't attack the person. We repair the protocol." If you've ever felt frustrated by your health journey, struggled with food cravings, or blamed yourself for not being able to "stick with it," this episode is for you. Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he's helped thousands of patients navigate hormonal imbalances using bioidentical HRT, nutrition, and root-cause medicine. He's also taught and mentored other physicians on integrative approaches to hormone therapy, weight loss, fertility, and more. If you're ready to take your health seriously, this podcast is a great place to start.
Welcome to the Patient from Hell podcast! Live from ASCO 2026, we explore breakthroughs in clinical oncology, cancer research, AI healthcare tools, and targeted therapy for advanced cancer.Samira Daswani, Founder and CEO of Manta Cares and host of The Patient From Hell, sits down with Dr. Doug Blayney, Chief Medical Officer of Manta Cares and former ASCO President, for a candid debrief in between sessions at the 2026 ASCO Annual Meeting in Chicago.With 45,000 oncology professionals in attendance, ASCO is the largest gathering of cancer researchers and clinicians in the world. In this episode, Samira and Dr. Blayney break down what actually mattered: the clinical findings, the shifting treatment landscape, and what the research trends mean for patients navigating cancer today.This episode is for oncologists, cancer researchers, and anyone who wants to understand where the field is heading.Topics covered, with more to come in our next episode:Key clinical findings from ASCO 2026Trends shaping experimental and clinical oncologyWhat high attendance and collaboration signals for the future of cancer researchWhat patients should know coming out of this year's conferenceCHAPTERS:0:00 - ASCO 2026 Annual Meeting Live from Chicago0:27 - Artificial Intelligence (AI) in Oncology & Patient Experience1:19 - Healthcare AI Challenges: Misinformation & Clinician Deskilling2:03 - Pancreatic Cancer Breakthrough: New RAS/KRAS Targeted Therapy2:30 - Lung Cancer Advancements: ALK Mutations & PD-L1 Data3:01 - Breast Cancer Innovation: Oral SERDs & ESR1 Biomarkers3:41 - Next Episode Preview & Wrap UpSubscribe for frequent breakdowns of cancer research, treatment news, patient stories, and guidance and support for people in treatment for cancer. Drop a comment with the topics or trials you want us to cover next!
Students from the new Waikato medical school will have placements in five regions around the country from 2029. Dr Nathalie de Vries, Chief Medical Officer at Whanganui Hospital spoke to Ingrid Hipkiss.
For the first time in decades, US officials confirmed new cases of the New World screwworm: a flesh-eating parasite that eats living tissue from the inside out and can cross over to humans. As the government prepares emergency declarations and a $750 million fly factory in Texas, McCullough Foundation epidemiologist Nicolas Hulscher reveals the not-so-surprising, over-the-counter medication that he says “provided more than 97% protection against screwworm infestations in wounds under real-world conditions.” But because it's so cheap and easily available, you will likely never hear about it in the headlines. In this special episode hosted by Dr. Kelly Victory, Nic Hulscher discusses the New World screwworm, ebola, and breaks down the meteoric rise of alpha-gal syndrome (meat allergies) and its connections to bio-engineered ticks. Nicolas Hulscher is an epidemiologist and administrator at the McCullough Foundation. He earned a Master of Public Health degree with a specialization in epidemiology at Michigan School of Public Health. He has contributed to the publication of more than 25 scientific studies, advancing understanding of COVID-19 vaccine injuries, childhood vaccine injuries, cancer treatments, SARS-CoV-2, and H5N1 avian influenza. Follow at https://x.com/NicHulscher Dr. Kelly Victory is Chief of Emergency & Disaster Medicine at The Wellness Company. A trauma and emergency specialist with over 30 years of experience, she served as Chief Medical Officer for Fortune 500 companies and is an alumna of Harvard's National Preparedness Leadership Initiative. She is a contributing author of “Toxic Shot: Facing the Dangers of the COVID Vaccines.” Find more at https://x.com/DrKellyVictory 「 SUPPORT OUR SPONSORS 」 • FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at https://drdrew.com/fatty15 • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at https://drdrew.com/paleovalley • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at https://twc.health/drew 「 ABOUT THE SHOW 」 This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Executive Producers • Kaleb Nation - https://kalebnation.com • Susan Pinsky - https://x.com/firstladyoflove Content Producer • Emily Barsh - https://x.com/emilytvproducer Learn more about your ad choices. Visit megaphone.fm/adchoices
(June 10, 2026) New law could create a million new apartments and condos in California. Americans on GLP-1s are overwhelming retailers with returns. Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany talks with Bill about adults and alcohol intake, egg allergies in kids, and GLP-1s appearing to cut cancer risk.See omnystudio.com/listener for privacy information.
In this episode, Rhonda Randall, DO, Executive Vice President and Chief Medical Officer, UnitedHealthcare, Commercial Business, Board member of the United Health Foundation, discusses findings from the America's Health Rankings 2026 Senior Report, highlighting encouraging gains in preventive care and physical activity alongside rising concerns around drug deaths, suicide, and food insecurity among older adults.
Synopsis: While biotech is increasingly measured by clinical milestones and financial outcomes, Rahul Chaturvedi welcomes two leaders who argue that true success begins and ends with patients. In this deeply personal and inspiring conversation, Mike Raab, President & Chief Executive Officer of Ardelyx, and Laura Williams, Chief Patient Officer, share how empathy, resilience, and patient advocacy have shaped both their careers and the culture of the company they've built. Mike reflects on an unconventional journey that spans pharmaceutical sales, rare disease leadership at Genzyme, venture capital at NEA, and ultimately leading Ardelyx through some of biotech's most difficult challenges—including a Complete Response Letter, massive layoffs, and a historic FDA reversal that resulted in approval without additional clinical trials. Laura shares her path from rural Mississippi to becoming a physician, recounting the transformative patient experience during the HIV epidemic that inspired her move from academia into industry and ultimately into a pioneering Chief Patient Officer role. Together, they explore what patient-centricity truly means beyond corporate slogans, how Ardelyx embedded patient advocacy into the C-suite, and why empathy must be a core competency for biotech leadership. The discussion also dives into clinical trial diversity, commercializing therapies for underserved populations, navigating regulatory adversity, responsible capital allocation, and the future of building enduring biotech companies. It is a powerful reminder that when patients become the North Star, resilience, innovation, and impact naturally follow. Biography: Mike Raab Mike has served as Ardelyx's President and Chief Executive Officer since March 2009. Before Ardelyx, Mike was a partner at New Enterprise Associates (NEA), one of the world's largest and most successful venture capital firms, where he specialized in healthcare investments focusing on the biotechnology and pharmaceutical sectors. Prior to joining NEA in 2002, Mike spent 15 years in commercial and operating leadership roles in the biotech and pharmaceutical industries. He was senior vice president, therapeutics and general manager of the renal division at Genzyme Corporation, a Sanofi company. In this position, Mike launched and oversaw the sales growth of sevelamer, the leading phosphate binder for the treatment of hyperphosphatemia, with over $1.0 billion in worldwide sales in 2013. Mike was also instrumental in the worldwide launch of Genzyme's therapies for Gaucher disease, Ceredase and Cerezyme. Laura Williams, MD, MPH Laura has served as Ardelyx's Chief Patient Officer since 2025, having joined the company in November 2020 as Senior Vice President, Global Therapeutic Strategies and Patient Advocacy. Laura was later promoted to Chief Medical Officer in 2021. Laura is a life science enterprise leader with extensive experience as a pharmaceutical drug developer, healthcare policy advisor, patient advocate, and portfolio strategist. She is an accomplished, results-oriented, physician scientist and board member who is committed to discovering, developing, and commercializing innovative therapies that address unmet medical need. With nearly 30 years of pharmaceutical experience, across all clinical development phases and multiple therapeutic areas, in both large pharma and smaller biotech, Laura has a proven track-record in drug development, as indicated by her leadership and major contributions toward eight drug approvals.
Join host Eve Cunningham, MD, Chief Medical Officer at Cadence, in conversation with Brian Stein, MD, Vice President and Chief Quality Officer at Rush University System for Health. Rush is a leading academic health system in Chicago with a national reputation for quality — ranked in Vizient's top 10 among academic medical centers for 13 consecutive years and a six-time U.S. News & World Report Best Hospitals Honor Roll honoree. In this episode, Drs. Eve and Brian explore how Rush has embedded quality into its organizational identity, what it takes to maintain consistent care in an academic medical center, and why remote patient monitoring became a strategic priority. Their conversation focuses on: How Rush treats quality as a brand differentiator rather than a compliance exercise — and the operational principles that make that sustainable Why academic medical centers face a unique quality challenge with trainee turnover every 2–4 years, and how tight processes compensate for that churn What made Rush an early adopter of remote patient monitoring, and the three-part filter Dr. Stein uses to evaluate any new technology Why patient retention on RPM surprised him more than the clinical outcomes — and what's driving long-term engagement How to think about short-term clinical wins versus long-term cost savings, and the payer misalignment that makes proving ROI difficult Where patient stratification is heading — matching the intensity of remote intervention to individual patient needs Where Rush is placing its bets on AI, from diagnostic radiology and pathology to virtual nursing and operational efficiency Dr. Stein is a partner of Cadence and not compensated for this podcast. Segments: [00:05] Introduction — Eve welcomes Dr. Stein to Cadence Conversations [00:39] Origin story — How research on administrative claims data led to a career in quality [04:02] Crew resource management — Team-based training and hardwired safety tools at Rush [05:46] Blood administration errors — How barcoding through Epic reduced a recurring safety issue [07:47] Quality as brand — Why Rush treats quality as a competitive differentiator, not a compliance exercise [09:47] Telling the quality story externally — CMS star ratings, US News rankings, and public credibility [11:36] Quality in an academic medical center — The trainee turnover challenge and why tight processes matter [14:52] Innovation and new care models — Why care beyond the walls became part of Rush's strategy [17:28] The case for RPM — Better outcomes, easier provider workflows, and not breaking the bank [20:34] What surprised him — Patient retention and engagement exceeded expectations [22:13] Evaluating the data — Blood pressure control, goal-directed therapy, and the cost-effectiveness question [24:30] Patient stratification — The future of high-touch vs. lighter-touch remote interventions [28:05] Research priorities — Short-term clinical wins vs. long-term cost savings and the payer challenge [31:50] Chronic disease as a lifetime journey — Why sustained engagement matters [33:09] AI at Rush — Augmented intelligence in radiology, pathology, virtual nursing, and access centers [36:23] Closing — Optimism grounded in a strong quality culture Key Takeaways: Quality becomes sustainable when it's treated as organizational brand identity, not a regulatory requirement — and when you make it easy for clinicians to do the right thing. Academic medical centers face a unique challenge: trainee turnover every 2–4 years means quality can't rely on individual education alone — it must be embedded in process and systems. The most surprising outcome of Rush's RPM journey was patient retention — patients stayed engaged for years in a program category where attrition is typically high. The future of remote care delivery is patient stratification: matching the intensity of the intervention (high-touch human + tech vs. lighter-touch tech-enabled) to the patient's needs. AI's near-term impact in health systems will be augmented intelligence — creating efficiency in diagnostics, operations, and access — not replacing clinical judgment.
According to the USDA, wheat ranks third after corn and soybeans with regard to its acreage, production, and farm receipts and is grown on roughly 37 million acres. Since its peak in 1981, wheat is now declining in acreage, down some 45 million acres which is perhaps the good news. Typically 1,000 acres in size, the average wheat farm is highly industrialized; as of 2020, some 150 different pesticides and herbicides were commonly sprayed on winter and spring wheat. Given the industrial scale of corn, soy, wheat, and cotton crops, heavy chemical usage of pesticides, herbicides, and fungicides has become business as usual. Our guest in this show from 2023, Dr. William Davis, Cardiologist and Author of the books Wheat Belly, Undoctored, and Super Gut [https://drdavisinfinitehealth.com/about/], exposes the problem with our wheat addiction and has connected the dots between gut health and common modern ailments and complaints. He observed over 80% of the people in his cardiology medical practice were pre-diabetic or diabetic. In an effort to reduce blood sugars, he had patients remove all wheat products from their diet based on the simple fact that foods made of wheat flour raise blood sugar higher than nearly all other foods. In 1958, approximately 1.6 million people were diagnosed with diabetes; that figure has skyrocketed now to 36 million people in 2023. It is estimated that roughly 75% of the population suffers from either insulin resistance, pre-diabetes or diabetes. The source of diabetes can often be traced back to the opioid-like addictive qualities of wheat and grains. Inflammation, obesity, celiac disease, heart disease, insulin resistance, cataracts, accelerated aging, skin issues, and neurodegenerative diseases constitute just some of the myriad problems that can arise from continued consumption of modern wheat and the supposed "healthy whole grains" that we've been encouraged to eat for a balanced diet. Dr. Davis shares how eliminating wheat and restoring our gut microbiomes are the means by which we might reclaim our personal, collective and ecosystem health. For an extended interview and other benefits, become an EcoJustice Radio patron at https://www.patreon.com/ecojusticeradio Dr. William Davis is a cardiologist and New York Times #1 bestselling author of the Wheat Belly book series [https://www.drdavisinfinitehealth.com/]. He is Medical Director and founder of the Infinite Health program including the Infinite Health Inner Circle [https://innercircle.drdavisinfinitehealth.com/]. He is Chief Medical Officer and co-founder of Realize Therapeutics Corp. that is developing innovative solutions for the disrupted human microbiome and author of the book Super Gut: A 4-Week Plan to Reprogram Your Microbiome, Restore Health, and Lose Weight. Carry Kim, Co-Host of EcoJustice Radio. An advocate for ecosystem restoration, indigenous lifeways, and a new humanity born of connection and compassion, she is a long-time volunteer for SoCal350, member of Ecosystem Restoration Camps, and a co-founder of the Soil Sponge Collective, a grassroots community organization dedicated to big and small scale regeneration of Mother Earth. LINKS Wheat Belly Series: https://drdavisinfinitehealth.com/wheat-belly/ Super Gut: https://drdavisinfinitehealth.com/super-gut/ MORE INFO Podcast Website: http://ecojusticeradio.org/ Podcast Blog: https://www.wilderutopia.com/category/ecojustice-radio/ Support the Podcast: Patreon https://www.patreon.com/ecojusticeradio PayPal https://www.paypal.com/donate/?hosted_button_id=LBGXTRM292TFC&source=url Executive Producer and Intro: Jack Eidt Hosted by Carry Kim Engineer and Original Music: Blake Quake Beats Episode 184
Oura AI Advisor with Dr. Ricky BloomfieldIn this episode of the Behavioral Design Podcast, hosts Aline and Samuel are joined by Dr. Ricky Bloomfield, Chief Medical Officer at Oura, to explore how AI is changing the way people understand, interpret, and act on their health data.Together, they examine what makes AI-powered health coaching feel different from traditional digital health tools. From conversational interfaces and biometric personalization to empathy, trust, uncertainty, and safety, Ricky shares a behind-the-scenes look at how Oura Advisor is designed to support people in making better health decisions without pretending to replace clinicians.The conversation covers:What makes a good health coach, whether human or AIWhy conversational AI can feel somewhere between a tool, coach, and companionHow Oura Advisor uses personal health data to make insights more relevant and actionableThe importance of empathy, tone, and response length in AI health experiencesWhy AI systems need guardrails without becoming overly constrainedThe risks and benefits of personalization, memory, and agentic AI in digital healthHow wearable data could help uncover silent health risks like high blood pressureWhy the future of health AI is less about replacing doctors and more about extending care, improving screening, and helping clinicians focus on higher-value workRicky's advice for product teams: optimize for speed of learningThis episode is a must-listen for anyone interested in the future of AI, digital health, wearables, and behavior change. Especially those thinking about how to design AI products that are not only intelligent, but trustworthy, humane, and genuinely useful.--Interesting in collaborating with Nuance? If you'd like to become one of our special projects, email us at hello@nuancebehavior.com or book a call directly on our website: nuancebehavior.com.Support the podcast by joining Habit Weekly Pro
Why do so many people continue to struggle with thyroid symptoms, hormone imbalances, fatigue, weight gain, digestive issues, and poor health even when their lab work looks "normal"? In this episode of The Thyroid Answers Podcast, Dr. Eric Balcavage sits down with board-certified endocrinologist Dr. Cassie Smith to discuss her new book, Fix Your Gut, Fix Your Hormones, and the critical role gut physiology plays in hormone health. Dr. Smith shares her journey from traditional endocrinology to a more physiology-based approach after recognizing that many of her patients continued to get sicker despite receiving standard medical treatment. Together, they explore how gut health, chronic stress, inflammation, lifestyle factors, and cellular physiology influence hormone production, hormone metabolism, thyroid function, insulin regulation, estrogen balance, and overall health. The conversation highlights why optimizing lab values alone often fails to resolve symptoms and why addressing the underlying physiologic patterns affecting the body may be a more effective path toward lasting health improvements. In This Episode, You'll Learn: Why many patients continue to struggle despite "normal" lab results How gut health influences thyroid hormone conversion and utilization The connection between chronic stress, gut dysfunction, and hormone imbalance Why insulin resistance is often driven by more than just diet The role of the gut microbiome in estrogen metabolism and detoxification How inflammation can affect hormone signaling at the cellular level Why hormone replacement does not always resolve symptoms The importance of addressing lifestyle, sleep, stress, nutrition, and gut function alongside hormone optimization How chronic physiologic strain may contribute to ongoing thyroid and hormone symptoms Why understanding physiology may be more important than chasing lab numbers Key Topics Discussed Gut microbiome and hormone metabolism Thyroid physiology and T4 to T3 conversion Insulin resistance and metabolic dysfunction GLP-1 physiology Estrogen metabolism and the estrobolome Chronic stress and allostatic load Inflammation and cellular hormone signaling Leaky gut and immune activation Functional medicine and root-cause approaches Hormone replacement therapy considerations Lifestyle factors that influence hormone health About Dr. Cassie Smith Dr. Cassie Smith, MD is a dual board-certified endocrinologist, Founder of Modern Endocrine, and Chief Medical Officer of Renthyroid. She also serves on the medical faculty of Evexias Medical, a bioidentical hormone company. Dr. Smith is known for helping patients uncover why they still feel unwell despite "normal" lab results by using a holistic, root-cause approach to gut, metabolic, thyroid, and hormonal health. After completing her fellowship at the Harold Hamm Diabetes Center and being named a Top Doctor by 405 Magazine, Dr. Smith grew frustrated with the limitations of conventional care and built a model focused on treating the whole person—not just symptoms. She is the author of Fix Your Gut, Fix Your Hormones: The Critical Connection Your Doctor Is Missing… and Why You Still Feel Bad Despite Normal Labs, and through her popular podcast, Hormones, Metabolism, and You, she translates complex endocrinology into practical, actionable guidance. Today, Dr. Smith and her team help thousands of patients each year get to the root cause of gut health issues, hormone imbalances, thyroid disease, and weight resistance. She is licensed to provide telehealth and in-clinic care across 47 states, based in Oklahoma. She is the author of Fix Your Gut, Fix Your Hormones and host of the Hormones, Metabolism, and You podcast. Resources & Links
Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about the death of Bulls legend Stacey King, a new study that shows flu medications have the potential to reduce cognitive decline as well as premature aging in people living with HIV, and an experimental vaccine from Moderna […]
Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about the death of Bulls legend Stacey King, a new study that shows flu medications have the potential to reduce cognitive decline as well as premature aging in people living with HIV, and an experimental vaccine from Moderna […]
What if aging is not only driven by what happens inside our cells, but also by factors circulating in our blood? In this thought-provoking episode, Dr. Gillian Lockitch talks with Brad Younggren to explore the emerging science behind therapeutic plasma exchange and its potential to influence inflammation, biological aging, and chronic disease. Drawing on human clinical trial data, including the Circulate Trial, he explains how removing pro-aging factors from plasma may impact biomarkers, biological age, and overall healthspan. This conversation offers a fascinating glimpse into the future of longevity medicine while reinforcing the importance of foundational lifestyle strategies for aging youthfully. Dr. Brad Younggren is the CEO and co-founder of Circulate Health, a company focused on advancing human healthspan through innovative therapies. He is a board-certified emergency physician and former U.S. Army combat physician, where he was awarded the Bronze Star and Combat Medical Badge. Dr. Younggren has held multiple leadership roles at the forefront of healthcare innovation, including President and Chief Medical Officer at 98.6, where he helped develop AI-powered primary care solutions. His career spans digital health, medical devices, and global healthcare delivery. Today, he leads research into therapeutic plasma exchange and its potential role in longevity science and chronic disease. Episode Timeline: 00:00 – Welcome and introduction 02:30 – Aging beyond the cell: circulating factors in the bloodstream and their role in inflammation and disease 05:00 – Dr. Younggren's journey from emergency medicine to healthcare innovation and longevity science 09:00 – The evolution of digital health and smartphone-based diagnostics 12:00 – What is therapeutic plasma exchange and how it has been used in medicine for decades 15:45 – The Circulate Trial explained: study design, treatment groups, and control methodology 18:30 – Measuring outcomes: biomarkers, cognitive testing, grip strength, and biological clocks 21:00 – Key findings: biological age reduction and changes in proteomic markers 24:30 – Translating complex science into practical biomarkers patients can track 26:30 – Applications beyond longevity: chronic disease, Alzheimer's research, and long COVID 30:30 – Microplastics and plasma exchange: emerging research and early findings 33:00 – Evaluating longevity therapies: why human data matters 35:30 – Foundational health habits versus advanced interventions 36:50 – Wrap-up and key takeaways Connect with Dr. Brad Younggren Circulate Health: https://www.circulate.health Circulate Trial publication (Aging Cell journal) Information on plasma exchange and ongoing research initiatives Call to Action: Find Growing Older Living Younger: The Science of Aging Gracefully and the Art of Retiring Comfortably (North America) or on Kindle Subscribe to Growing Older Living Younger on your favorite podcast platform and leave a review to help others discover the show. Join the Growing Older Living Younger Community Connect with Dr. Gillian Lockitch at https://www.askdrgill.com/ or email: askdrgill@gmail.com Download Guide to Nature's Colorful Antioxidants. 2026
In this episode, we are joined by Dr. Matt Bernstein, MD, Chief Medical Officer at Ellenhorn and Chief Executive Officer of Accord. A highly respected clinical psychiatrist and leading voice in the emerging field of metabolic psychiatry, Dr. Bernstein draws on more than 25 years of experience helping individuals achieve meaningful mental health improvement and long-term functional recovery. Throughout his career, Dr. Bernstein has explored the connection between metabolism and mental health, first through private practice and later through his work at Ellenhorn. More recently, he developed Accord's comprehensive treatment model and has become a prominent advocate for metabolic psychiatry through podcasts, national conferences, and briefings for members of Congress. This conversation dives into: What metabolic psychiatry is and how it differs from traditional psychiatric care. The relationship between brain metabolism and mental health disorders. How ketogenic therapies are being explored as potential tools for psychiatric recovery. The role of metabolic health in conditions such as depression, bipolar disorder, schizophrenia, anxiety, OCD, and psychosis. Dr. Bernstein graduated summa cum laude from Columbia University with a degree in English Literature and earned his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed his psychiatric training at MGH/McLean, where he served as Chief Resident and later held leadership positions, including Psychiatrist-in-Charge and Assistant Medical Director of the Schizophrenia and Bipolar Inpatient Program. He also serves on several advisory and nonprofit boards, including Metabolic Mind, Meru Health, The Metabolic Revolution, and the Coalition for Metabolic Health. Connect with Dr. Bernstein: LinkedIn Accord's Website Ellenhorn's Website
Today, I am delighted to reconnect with Dr. William Davis. He's a cardiologist, New York Times bestselling author of the Wheat Belly book series, and author of Super Gut. He is also the founder and Medical Director of the Infinite Health Program and the co-founder and Chief Medical Officer of Realize Therapeutics Corp, which is developing innovative solutions to restore and support the human microbiome. In our conversation, we explore the microbiome and how it is influenced by key changes in a woman's life, including pregnancy and premature delivery, as well as how modern lifestyle factors disrupt our microbiome. Dr. Davis discusses endotoxemia and dysbiosis in fertility, uterine health, and cardiovascular disease, as well as antibiotic use, statins, atrial fibrillation, the role of blood glycocalyx, TMAO, and the dietary approach he considers important. He also discusses appropriate prescribed antibiotic use in the context of microbiome disruption. Stay tuned for another fascinating discussion with Dr William Davis on the far-reaching impact of the microbiome on women's health, heart health, and longevity. I look forward to having Dr. Davis back on the show! IN THIS EPISODE, YOU WILL LEARN: How factors such as omega-3 fatty acid intake and microbiome health may affect pregnancy outcomes. How microbial health extends beyond the gastrointestinal tract and can influence multiple organ systems The disruptive effects of antibiotics, glyphosate, food preservatives, and emulsifiers on the microbiome Dr. Davis describes how endotoxemia can affect the brain, skin, joints, metabolism, and cardiovascular system. How endotoxemia influences multiple cardiovascular risk markers How endotoxemia and glycation can contribute to atrial fibrillation The role of the glycocalyx, and how damage to the integrity of the glycocalyx could influence arterial function and cardiovascular risk Why fermented foods remain a key strategy for microbiome diversity Dr. Davis shares his dietary choices and his approach to microbiome support Bio: William Davis, MD William Davis, MD, is a cardiologist and #1 New York Times bestselling author of the Wheat Belly series of books, as well as Undoctored and Super Gut. Recent human clinical trials that Dr. Davis conducted have revealed that it is possible to lose fat weight while preserving muscle, thereby preventing weight regain and enjoying improved body composition, findings that inspired the writing of Bulge. Dr. Davis is also Chief Medical Officer at Realize Therapeutics Corp., which he co-founded to explore the new science of the microbiome to improve health and appearance, including body composition. Connect with Cynthia Thurlow Follow on X, Instagram & LinkedIn Check out Cynthia's website. Submit your questions to support@cynthiathurlow.com Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow. Purchase Cynthia's book, The Menopause Gut. Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line Connect with Dr. William Davis On his website Join Dr Davis's Inner Circle Dr. Davis's books
June 5, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Vida Health partners with Instacart Health to turn nutrition guidance into grocery purchases via Fresh Funds stipends, reaching 98% of US households including food desert communities Athletic Brewing launches largest-ever summer campaign increasing media spend 120% with first MLB partnership featuring Dodgers star Teoscar Hernández as off-premise sales rise 24% Hims appoints longevity medicine expert Dr. Anant Vinjamoori as Chief Medical Officer, signaling expansion beyond hair loss into metabolic health, hormones, and regenerative medicine Today's episode is brought to you by AIIR — a modern communications and experiential agency for health, wellness, fitness, and performance brands. From earned media to events and creator-led campaigns, AIIR helps companies sharpen their story, earn attention, and build trust that compounds. Visit https://aiir.agency to learn more. More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → insider@fitt.co
Full Show Notes: https://bengreenfieldlife.com/timelinereplay In this special replay episode with repeat guest Dr. Anurag Singh from Timeline Nutrition, you'll explore the science of cellular health and longevity, including why mitochondrial function affects everything from energy and muscle performance to cognitive clarity and how well you age. Dr. Singh explains how urolithin A, a postbiotic compound derived from foods like pomegranates and berries, activates mitophagy, the body's cellular clean-up system that clears out worn-out mitochondria and replaces them with new ones, and how clinical research shows it can support muscle strength, endurance, immune resilience, and cognitive function. You'll also hear how diet, gut health, exercise, sleep, and recovery work alongside urolithin A to build a stronger, more resilient physiology over time. Dr. Anurag Singh is Chief Medical Officer at Timeline Nutrition, with an M.D. in internal medicine and a Ph.D. in immunology. He has authored more than 50 scientific articles, been awarded over 20 patents, and led more than 50 randomized clinical trials. His decade of research on urolithin A has produced multiple clinically validated products bringing longevity science directly to consumers. Episode Sponsors: BON CHARGE: A holistic wellness brand with products that address sleep, performance, recovery, hormone balance, and inflammation. Go to boncharge.com/GREENFIELD and use code GREENFIELD to save 15%. Troscriptions: A buccal troche delivery system that bypasses digestion to deliver pharmaceutical-grade compounds directly through your cheek mucosa for faster onset and higher bioavailability. Visit troscriptions.com/BEN or use code BEN for 10% off your first order. Timeline: High-performance products powered by Mitopure, delivering a precise dose of urolithin A for healthy aging. Mitopure starts at $79 at timeline.com/BEN. Just Thrive: The Gut Essentials Bundle pairs a probiotic clinically proven to arrive 100% alive in your gut with Digestive Bitters, a blend of 12 science-backed herbs. Visit justthrivehealth.com/BEN and save 20% with code BEN, or get a full refund if you don't notice a difference. Young Goose: To experience the transformative power of Young Goose's cutting-edge skincare products, visit younggoose.com and use code BGF10 at checkout to enjoy a 10% discount on your order. Manukora: You haven’t tasted or seen honey like this before, so indulge and try some honey with superpowers from Manukora. If you head to manukora.com/ben or use code BEN, you’ll automatically get $25 off your Starter Kit. See omnystudio.com/listener for privacy information.
In this episode, Erik Summers, MD, Chief Medical Officer, Division of Hospital Medicine at the Medical University of South Carolina, joins the podcast to discuss how healthcare organizations can attract and retain physicians through culture, transparency, and personalized recruitment experiences.
Tech entrepreneur Steve Kirsch used advanced AI to analyze raw, independent datasets about mRNA injuries – and uncovered what “no public health official wants to know.” Legacy media continues to ignore the staggering reality of adverse reactions and side effects of mRNA for COVID-19. Steve Kirsch took matters into his own hands – and his latest analysis estimates that as many as 2 million Americans were seriously disabled by the shots. He joins Dr. Kelly Victory to share his methods, how he used AI to analyze the data, and why “not a single national public-health authority, anywhere in the world, has produced an estimate of the type we just constructed.” Steve Kirsch is a former Silicon Valley high-tech executive with two engineering degrees from MIT. He founded the COVID-19 Early Treatment Fund and the Vaccine Safety Research Foundation (VSRF). He hosts the VSRF Live Weekly Update and has authored more than 1,900 articles on vaccine safety at kirschsubstack.com. Follow at https://x.com/stkirsch Dr. Kelly Victory is Chief of Emergency & Disaster Medicine at The Wellness Company. A trauma and emergency specialist with over 30 years of experience, she served as Chief Medical Officer for Fortune 500 companies and is an alumna of Harvard's National Preparedness Leadership Initiative. She is a contributing author of “Toxic Shot: Facing the Dangers of the COVID Vaccines.” Find more at https://x.com/DrKellyVictory 「 SUPPORT OUR SPONSORS 」 • FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at https://drdrew.com/fatty15 • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at https://drdrew.com/paleovalley • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at https://twc.health/drew 「 ABOUT THE SHOW 」 This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Executive Producers • Kaleb Nation - https://kalebnation.com • Susan Pinsky - https://x.com/firstladyoflove Content Producer • Emily Barsh - https://x.com/emilytvproducer Hosted By • Dr. Drew Pinsky - https://x.com/drdrew Learn more about your ad choices. Visit megaphone.fm/adchoices
(June 03, 2026) Election recap: What are we looking at in November? CA Governor race/ LA Mayor race. Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany speaks on why a British hospital opened an ICU ward on a roof, a common sleep drug could impair driving the next day, and whether you should always get a 2nd opinion.See omnystudio.com/listener for privacy information.
After kids, a lot of couples assume intimacy is supposed to disappear. You're exhausted, touched-out, overwhelmed by logistics, carrying invisible mental load — and somewhere along the way, sex can start to feel complicated, distant, or impossible to even talk about. But what if the story is more nuanced than that? In this episode, Dr. Becky talks with board-certified OB/GYN, sexual wellness expert, and Chief Medical Officer at Hers, Dr. Jessica Shepherd, about new survey data exploring what actually happens to intimacy in long-term relationships and parenthood. They discuss: why some married couples report better sex after kids how vulnerability changes intimacy the connection between mental load and desire hormones, perimenopause, and libido why “whose fault is this?” is often the wrong question what it means to approach intimacy from a same-team perspective This conversation is honest, practical, funny at times — and ultimately hopeful. Because intimacy is about feeling seen, understood, connected, and able to locate yourself inside your relationship again. Dr. Becky wrote up a few tips for talking to your partner about intimacy after kids. You can read those here. Thank you to our partners for making this episode possible: Skylight: Get $30 off a 15-inch Skylight Calendar at myskylight.com/becky LMNT: Get a free 8-count sample pack with your purchase at LMNT.com/goodinside Oso & Me: Use the code OSOGOOD15 for 15% off clothes newborn through age ten Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.